Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,377,152 | 1,492,971 | 1,550,004 | 1,739,056 | 38 |
| Receivables | 174,877 | 171,070 | 136,142 | 50,725 | N/A |
| Inventories | 8,102 | 8,697 | 3,362 | 3,474 | N/A |
| TOTAL | $1,598,848 | $1,705,832 | $1,723,045 | $1,810,569 | $967 |
| Non-Current Assets | |||||
| PPE Net | 176,221 | 149,171 | 145,770 | 142,704 | N/A |
| Investments And Advances | 95,982 | 111,238 | 115,231 | 121,128 | 0 |
| Intangibles | 70,153 | 41,869 | 42,954 | 39,228 | 0 |
| Other Non-Current Assets | 53,015 | 49,616 | 43,990 | 36,962 | 1,725,021 |
| TOTAL | $395,371 | $351,894 | $347,945 | $340,022 | $1,725,021 |
| Total Assets | $1,994,219 | $2,057,726 | $2,070,990 | $2,150,591 | $1,725,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,459 | 35,257 | 8,189 | 7,102 | 4,689 |
| Accrued Expenses | 70,059 | 88,758 | 93,332 | 53,554 | N/A |
| TOTAL | $135,022 | $159,247 | $134,761 | $90,305 | $4,689 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 45,504 | 35,232 | 33,240 | 29,649 | N/A |
| Other Non-Current Liabilities | 65,146 | 69,772 | 176,169 | 246,569 | 1,656,447 |
| TOTAL | $292,141 | $284,431 | $368,850 | $442,315 | $1,716,299 |
| Total Liabilities | $427,163 | $443,678 | $503,611 | $532,620 | $1,720,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,421 | 37,216 | 36,790 | 37,168 | 5,391 |
| Common Shares | 164 | 162 | 161 | 148 | 7 |
| Retained earnings | -3,557,255 | -2,888,430 | -2,297,925 | -697,269 | -100,999 |
| Other shareholders' equity | 26,129 | 30,898 | 60,299 | 65,543 | 0 |
| TOTAL | $1,567,056 | $1,614,048 | $1,567,379 | $1,617,971 | $5,000 |
| Total Liabilities And Equity | $1,994,219 | $2,057,726 | $2,070,990 | $2,150,591 | $1,725,988 |